Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

There are certain symptoms which include blood in urine (hematuria), flank or lower back pain, a palpable lump in the ...

While fever is typically a sign of infection, a persistent, unexplained fever without any identifiable cause could be an ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

Dr. Michael Serzan explains the importance of clinical trial enrollment for patients with kidney cancer and highlighted findings from the STELLA-002 trial.

Persistent fever without infection could be a hidden sign of kidney cancer, according to experts. Other symptoms may include ...

Lupus can be debilitating and sometimes deadly for the 3 million people who have it. A treatment called CAR T appears to stop ...

The most common TRAEs of any grade were acneiform rash (93%), diarrhea (89%), proteinuria (78%), and dry skin (64%).

Ahead of World Kidney Cancer Day on June 19, the American Kidney Fund (AKF) today announced a new educational campaign on renal (kidney) cancer. With support from Merck, this campaign will provide ...

Scientists have discovered tumors can tap a nontraditional pathway to acquire lipoproteins—molecules that transport fat in ...

Dr. Michael Serzan provides expert takeaways on treatment updates for patients with early-stage kidney cancer following the 2025 ASCO Meeting.

The NDA for sintilimab plus fruquintinib targets advanced renal cell carcinoma patients who failed prior TKI treatment, addressing an unmet need in China. The FRUSICA-2 trial showed improved PFS, ORR, ...